Risk factors associated with HTN included AKI defined as doubling of baseline creatinine by day 100 after HCT, total body irradiation in preparative regimen, autologous donor type more so than unrelated donor type, obesity, diabetes, and history of growth hormone therapy. Here, GH1 is linked to obesity disorder.